LPLV 2 Months Ahead of Schedule
ARG CEO Paul Bishop just received the following feedback from a Global Pharmaceutical Sponsor: “LPLV occurred on Friday. Congrats to […]
ARG Strategic Advisory Board Meeting 5/24
The ARG SAB (Strategic Advisory Board) regularly convenes to discuss emerging trends and issues in rare diseases, adding to the […]
ARG Presence at Alliance For Regenerative Medicine Annual Dinner & Legislative Fly-In
Jeff Cazeault, Head of Business Development at ARG, is in Washington, DC to attend the Alliance for Regenerative Medicine Annual […]
ARG Team Attends Rare Disease Week on Capitol Hill
Three ARG team members attended 2018 Rare Disease Week on Capitol Hill: Senior Data Manager Darlene Adams, Project Manager Catherine […]
Flexible and Lightweight CRO Education: ARG Chrysalis Leads The Way
One of the main reasons why ARG has consistently produced excellent clinical trial work over the years has been because […]